BIOMAT Database Logo BIOMAT Database Logo

Phase II study of N-methylformamide in patients with advanced colorectal cancer. 1987

N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005559 Formamides A group of amides with the general formula of R-CONH2.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase II trial of N-methylformamide in patients with advanced colorectal carcinoma.
June 1986, Cancer treatment reports,
N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase I study of N-methylformamide in patients with advanced cancer.
May 1985, Cancer treatment reports,
N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase II study on oral N-methylformamide in metastatic colorectal cancer.
December 1987, Cancer treatment reports,
N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase II trial of N-methylformamide in advanced renal cancer.
February 1989, American journal of clinical oncology,
N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase II trial of N-methylformamide in advanced head and neck cancer.
January 1987, Investigational new drugs,
N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer. A Gynecologic Oncology Group study.
May 1990, Investigational new drugs,
N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group study.
May 1990, Investigational new drugs,
N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase II trial of N-methylformamide in lung cancer.
August 1992, Investigational new drugs,
N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase II study of flavopiridol in patients with advanced colorectal cancer.
August 2003, Annals of oncology : official journal of the European Society for Medical Oncology,
N S Tchekmedyian, and R S Kaplan, and M Eisenberger, and J Abrams, and D Van Echo
Phase II trial of N-methylformamide in patients with metastatic melanoma.
February 1991, Investigational new drugs,
Copied contents to your clipboard!